Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00052520
Status:
COMPLETED
Last Update Posted:
2017-03-29
First Post:
2003-01-24
Brief Title:
Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome Acute or Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| T-cell Childhood Acute Lymphoblastic Leukemia |
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myeloid Leukemia With Inv16p13q22 |
| Adult Acute Myeloid Leukemia With t1517q22q12 |
| Adult Acute Myeloid Leukemia With t1616p13q22 |
| Adult Acute Myeloid Leukemia With t821q22q22 |
| B-cell Adult Acute Lymphoblastic Leukemia |
| B-cell Childhood Acute Lymphoblastic Leukemia |
| Childhood Chronic Myelogenous Leukemia |
| Childhood Myelodysplastic Syndromes |
| Chronic Myelomonocytic Leukemia |
| Essential Thrombocythemia |
| Polycythemia Vera |
| Previously Treated Myelodysplastic Syndromes |
| Recurrent Adult Acute Lymphoblastic Leukemia |
| Recurrent Adult Acute Myeloid Leukemia |
| Recurrent Childhood Acute Lymphoblastic Leukemia |
| Recurrent Childhood Acute Myeloid Leukemia |
| Refractory Anemia With Excess Blasts |
| Refractory Anemia With Excess Blasts in Transformation |
| Relapsing Chronic Myelogenous Leukemia |
| Secondary Acute Myeloid Leukemia |
| T-cell Adult Acute Lymphoblastic Leukemia |
Keywords: